tiprankstipranks
Fate Therapeutics (FATE)
NASDAQ:FATE

Fate Therapeutics (FATE) Stock Investors

1,098 Followers
Based on 730,878 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold FATE
On average, investors allocate 2.79% of their portfolios to FATE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 730,878 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding FATE

0.7%
Last 7
Days
0.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding FATE, out of 730,878 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

FATE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.00%
$3.77
Based on the activity of 13,735 investors who made their portfolios public
The table shows changes in FATE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

FATE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Block
4.46%
-0.41%
-3.68%
45.86B
Technology
Trade Desk
4.68%
-0.07%
-0.84%
41.43B
Technology
Merck & Company
4.16%
+0.15%
+1.94%
332.28B
Healthcare
Mercadolibre
5.27%
+0.59%
+1.50%
71.28B
Consumer Cyclical
ServiceNow
3.94%
+1.54%
+2.08%
148.33B
Technology
ChargePoint Holdings
3.88%
-0.97%
-3.22%
537.67M
Consumer Cyclical
GE Aerospace
5.53%
<+0.01%
+12.57%
177.71B
Industrials
Shopify
5.63%
-0.77%
-1.67%
91.71B
Technology
Citigroup
5.15%
+0.10%
+1.01%
120.01B
Financial
Qualcomm
4.81%
<+0.01%
-1.43%
184.88B
Technology
Based on the activity of 730,878 active portfolios
Open your Smart Portfolio

FATE Investor Analysis

FATE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.5%
of FATE holders
are under 35
Average Segment Performance
Average P/E Ratio56.32
Beta6.59
Dividend Yield6.13%
FATE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
55.3%
of FATE holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.35
Beta11.34
Dividend Yield17.67%
FATE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
30.2%
of FATE holders
are over 55
Average Segment Performance
Average P/E Ratio52.26
Beta4.21
Dividend Yield22.32%
Overview of age group and performance of FATE stock investors
See who invests in FATE according to age group and performance.

FAQ

How many retail Investors hold FATE?
<0.1% of TipRanks' retail investors hold FATE in their portfolios.
    What is FATE Investor Sentiment?
    FATE’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of FATE in the last 7 days?
      ▲ 0.7% of TipRanks' retail investors changed their holding of FATE in the last 7 days.
        What percentage of retail investors changed their holding of FATE in the last 30 days?
        ▼ 0.6% of TipRanks' retail investors changed their holding of FATE in the last 30 days.
          What is the average age of retail investors who hold FATE?
          The average age of FATE Holders is between 35–55.
            What other stocks have FATE investors also bought?
            FATE Investors also bought SQ, TTD, MRK, MELI, NOW, CHPT, GE, SHOP, C, QCOM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CORTCorcept Therapeutics
              GERNGeron
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis